| Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020 | 2535 | 2020 |
| Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... Science 370 (6515), eabd4570, 2020 | 2192 | 2020 |
| Pyogenic bacterial infections in humans with IRAK-4 deficiency C Picard, A Puel, M Bonnet, CL Ku, J Bustamante, K Yang, C Soudais, ... Science 299 (5615), 2076-2079, 2003 | 1097 | 2003 |
| Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency S Dupuis, E Jouanguy, S Al-Hajjar, C Fieschi, IZ Al-Mohsen, S Al-Jumaah, ... Nature genetics 33 (3), 388-391, 2003 | 929 | 2003 |
| Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis L Liu, S Okada, XF Kong, AY Kreins, S Cypowyj, A Abhyankar, J Toubiana, ... Journal of Experimental Medicine 208 (8), 1635-1648, 2011 | 876 | 2011 |
| Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity J Bustamante, S Boisson-Dupuis, L Abel, JL Casanova Seminars in immunology 26 (6), 454-470, 2014 | 733 | 2014 |
| IRF8 Mutations and Human Dendritic-Cell Immunodeficiency S Hambleton, S Salem, J Bustamante, V Bigley, S Boisson-Dupuis, ... New England Journal of Medicine 365 (2), 127-138, 2011 | 668 | 2011 |
| A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection E Jouanguy, S Lamhamedi-Cherradi, D Lammas, SE Dorman, ... Nature genetics 21 (4), 370-378, 1999 | 615 | 1999 |
| Impairment of Mycobacterial But Not Viral Immunity by a Germline Human STAT1 Mutation S Dupuis, C Dargemont, C Fieschi, N Thomassin, S Rosenzweig, J Harris, ... Science 293 (5528), 300-303, 2001 | 598 | 2001 |
| Inborn errors of IL-12/23-and IFN-γ-mediated immunity: molecular, cellular, and clinical features O Filipe-Santos, J Bustamante, A Chapgier, G Vogt, L de Beaucoudrey, ... Seminars in immunology 18 (6), 347-361, 2006 | 596 | 2006 |
| Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency D Bogunovic, M Byun, LA Durfee, A Abhyankar, O Sanal, D Mansouri, ... Science 337 (6102), 1684-1688, 2012 | 546 | 2012 |
| Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation X Zhang, D Bogunovic, B Payelle-Brogard, V Francois-Newton, SD Speer, ... Nature 517 (7532), 89-93, 2015 | 531 | 2015 |
| IL-12 and IFN-γ in host defense against mycobacteria and salmonella in mice and men E Jouanguy, R Döffinger, S Dupuis, A Pallier, F Altare, JL Casanova Current opinion in immunology 11 (3), 346-351, 1999 | 477 | 1999 |
| Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries L De Beaucoudrey, A Samarina, J Bustamante, A Cobat, ... Medicine 89 (6), 381-402, 2010 | 449 | 2010 |
| B cell–intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans DT Avery, EK Deenick, CS Ma, S Suryani, N Simpson, GY Chew, ... Journal of Experimental Medicine 207 (1), 155-171, 2010 | 440 | 2010 |
| Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations S Okada, JG Markle, EK Deenick, F Mele, D Averbuch, M Lagos, ... Science 349 (6248), 606-613, 2015 | 424 | 2015 |
| Inborn errors of interferon (IFN)‐mediated immunity in humans: insights into the respective roles of IFN‐α/β, IFN‐γ, and IFN‐λ in host defense SY Zhang, S Boisson‐Dupuis, A Chapgier, K Yang, J Bustamante, A Puel, ... Immunological reviews 226 (1), 29-40, 2008 | 387 | 2008 |
| Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor β1 deficiency: medical and immunological implications C Fieschi, S Dupuis, E Catherinot, J Feinberg, J Bustamante, A Breiman, ... The Journal of experimental medicine 197 (4), 527-535, 2003 | 358 | 2003 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 348 | 2021 |
| Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome AY Kreins, MJ Ciancanelli, S Okada, XF Kong, N Ramírez-Alejo, SS Kilic, ... Journal of Experimental Medicine 212 (10), 1641-1662, 2015 | 344 | 2015 |
